RiceBran Technologies (NASDAQ:RIBT) announced its quarterly earnings data on Tuesday. The company reported ($0.11) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.12) by $0.01, Fidelity Earnings reports. RiceBran Technologies had a negative return on equity of 42.74% and a negative net margin of 56.23%.
NASDAQ:RIBT opened at $0.85 on Wednesday. RiceBran Technologies has a twelve month low of $0.48 and a twelve month high of $3.76. The company has a current ratio of 1.61, a quick ratio of 1.44 and a debt-to-equity ratio of 0.11. The company has a 50-day moving average of $1.11 and a 200-day moving average of $1.89. The firm has a market cap of $33.58 million, a price-to-earnings ratio of -2.06 and a beta of 0.22.
Separately, Lake Street Capital lowered their target price on RiceBran Technologies from $4.50 to $2.50 and set a “positive” rating on the stock in a report on Tuesday, January 14th.
RiceBran Technologies processes and markets healthy, natural, and nutrient dense products derived from raw rice bran. The company manufactures and distributes stabilized rice bran (SRB) in various granulations with other products and derivatives. It offers RiBalance, a rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich derivative of RiBalance; and protein and protein/fiber blends under the ProRyza brand.
Further Reading: Is a Roth IRA right for you?
Receive News & Ratings for RiceBran Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RiceBran Technologies and related companies with MarketBeat.com's FREE daily email newsletter.